Group items tagged

The Association of Reptilian and Amphibian Veterinarians works to advance programs for preventative medicine, husbandry, and scientific research in the field of veterinary medicine dealing with reptiles and amphibians. ARAV also distributes scientific information relating to the field of husbandry, veterinary medicine, and surgery of reptiles and amphibians through the Journal of Herpetological Medicine and Surgery, the official publication of the association, and the annual conference of the association.

This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements will improve the detection of antibiotic resistance among enteric bacteria in food commodities, as well as potentially develop new sites as part of the program. Measurable outcomes of the program will be in alignment with the NARMS Objectives.

This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements will improve the detection of antibiotic resistance among enteric bacteria in food commodities, as well as potentially develop new sites as part of the program. Measurable outcomes of the program will be in alignment with the NARMS Objectives.

The purpose of IFER's Fellowship Program is to provide financial incentives to graduate students in science that encourage them at the earliest stages of their career to integrate innovation and discovery with ethics and respect for animals. Fellowships are awarded to those candidates whose program of study shows the greatest potential to replace the use of animals in science. Graduate Fellowships to develop alternatives to the use of animals in research, testing and education are open to students enrolled in Master's and Ph.D. programs in the sciences, and human or veterinary medicine. Fellowships will also be considered for graduate students in other fields, such as education, psychology, humanities, journalism, and the law, for projects that show promise to increase public awareness or to promote changes in the legal system or public policy regarding the use of animals in research, testing, and education.

NineSigma, representing a major Global Veterinary Company, invites proposals for methods to significantly reduce  Campylobacter gut load in broiler chickens.

This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements will improve the detection of antibiotic resistance among enteric bacteria in food commodities, as well as potentially develop new sites as part of the program. Measurable outcomes of the program will be in alignment with the NARMS Objectives.

The Scleroderma Foundation seeks applications from established investigators both inside and outside the field of scleroderma research for pilot studies designed to obtain preliminary data regarding a highly innovative and/or highly relevant theme related to the disease. The grant is intended to support pilot research likely to lead to more substantial research project grants from federal or non-federal sources. Applications may be submitted by U.S. nonprofit organizations, public and private, including universities, colleges, hospitals, and laboratories. Foreign organizations and institutions are eligible to apply as well. Applicants must have a doctorate degree in medicine, osteopathy, veterinary medicine, or one of the sciences; have completed a postdoctoral fellowship; and have been principal investigator on grants from the Scleroderma Foundation or other national, private, or government agencies in the past. Applicants may request up to $75,000 per year for up to two years.

This call is open to all respondents, and we particularly encourage proposals from the private sector and/or entities that have partnerships with the private sector - to ensure a pathway to commercialization at scale. Our first principle is to leverage existing innovation within the food and beverage industry and its suppliers for new applications that can reach low-income consumers, for greatest scale and impact. We also welcome technologies and translational approaches based on knowledge from ancillary fields, e.g., veterinary science, pharmaceuticals, etc.

This Funding Opportunity Announcement (FOA) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop, or support the development of new animal drugs intended for minor use in major species or for use in minor species.

The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in careers in biomedical, behavioral, or clinical research. Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive, short-term research training experiences for health professional students (medical students, veterinary students, and/or students in other health-professional programs) during the summer. This program is also intended to encourage training of graduate students in the physical or quantitative sciences to pursue research careers by short-term exposure to, and involvement in, the health-related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of biomedical research. This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in careers in biomedical, behavioral, or clinical research. Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive, short-term research training experiences for health professional students (medical students, veterinary students, and/or students in other health-professional programs) during the summer. This program is also intended to encourage training of graduate students in the physical or quantitative sciences to pursue research careers by short-term exposure to, and involvement in, the health-related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of biomedical research.